Tests genetic testing to guide psychiatric medicine choices in Manitoba
Tests genetic testing to guide medicine choices in adults with mental illness.
Plain-language title generated from the registry record
Registry title: Pharmacogenomics-Supported Psychotropic Prescribing Trial
Key facts
- Where
- Winnipeg, CanadaSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in Manitoba who need to start or change psychiatric medicine and are referred by their clinician for a genetic test (PGx) of how they process drugs.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- People with a mental illness for whom starting, changing, adjusting the dose of, or adding a psychotropic medicine is planned
Main reasons for not taking part
- Not willing to give saliva samples for genetic testing
- Past liver or bone marrow (hematopoietic cell) transplant
- PGx test results already available
- No personal health identification number (PHIN)
Read by machine on 12 November 2026.
Where in Canada
- Shared Health FacilitiesWinnipeg, CanadaContact: Abdullah Al Maruf, PhD, M.Pharm, B.PharmNot yet recruiting
- University of Manitoba College of PharmacyWinnipeg, CanadaContact: Abdullah Al Maruf, PhD, M.Pharm, B.PharmTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Manitoba
- Trial code
- NCT06929533
- Record updated
- 8 September 2025
- Original description
Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.Read full original descriptionShow less
Pharmacogenomics-Supported Psychotropic Prescribing Trial (PGx-SUPPORT): A Pilot Implementation Study in Manitoba
Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.
Inclusion: Aged 18 years or older; The initiation, change, dose adjustment, or augmentation of psychotropic medication(s) is indicated; The treating clinician thinks PGx testing can benefit and refers the patient to the study.
Exclusion: History of liver or bone marrow (hematopoietic cell) transplantation; Unwillingness to donate saliva samples for genetic analysis; PGx testing results are already available; No personal health identification number (PHIN) is available.